Meresasul

Sulpiride, the active ingredient in Meresasul, is a benzamide antipsychotic presented as an oral tablet for oral use. It is employed to manage schizophrenia, depressive disorders and anxiety in adult patients, acting on dopaminergic pathways to alleviate psychotic and mood symptoms.

GNH USA supplies Meresasul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured product availability across global markets. The product is manufactured in the European Union following EU GMP standards, providing a reliable source for mental health therapeutics.

Sulpiride is a benzamide antipsychotic that modulates dopaminergic pathways in several psychiatric conditions.

Schizophrenia: reduces positive and negative symptoms, improving overall psychotic stability. Depressive disorders: used as an adjunct to enhance mood and alleviate depressive symptoms in resistant cases. Anxiety: helps to lessen anxiety manifestations in patients with comorbid psychiatric conditions.

Sulpiride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Drowsiness: increased sleepiness or fatigue. - Extrapyramidal symptoms: tremor, rigidity, or akathisia. - Weight gain: gradual increase in body weight. - Dry mouth: reduced salivation. - Constipation: slowed bowel movements.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening fever, muscle rigidity and autonomic instability. - Severe hyperprolactinemia: galactorrhea, menstrual disturbances or sexual dysfunction. - Cardiac arrhythmias: irregular heart rhythm that may require medical attention.

When prescribing sulpiride, clinicians should consider several precautionary measures to ensure safe use.

- Dose adjustment in renal impairment: reduce dose according to renal function. - Monitor extrapyramidal symptoms: assess motor function regularly. - Assess prolactin levels: watch for galactorrhea or menstrual changes. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Sulpiride can interact with other medicines, affecting its plasma levels or enhancing adverse effects.

Major Interactions (Avoid): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase sulpiride concentrations. - Antihypertensive agents: additive hypotensive effect leading to low blood pressure. - Anticholinergic drugs: may mask extrapyramidal symptoms, complicating monitoring.

Moderate Interactions (Monitor Closely): - Other dopamine antagonists (e.g., haloperidol): increased risk of extrapyramidal side effects. - Lithium: potential for enhanced neurotoxicity. - Alcohol: may intensify sedation and dizziness.